| Images |
Sources |
Experiment + Assay |
Phenotypes |
Human Diseases |
|
fig.8.a
Kenny AP et al. (2012)
|
Xla Wt + szl MO
NF10.5 (in situ hybridization)
|
|
|
|
|
fig.8.a
Kenny AP et al. (2012)
|
Xla Wt + szl MO
NF18-20 (immunohistochemistry)
|
|
|
|
|
fig.8.a
Kenny AP et al. (2012)
|
Xla Wt + szl MO
NF18-20 (in situ hybridization)
|
|
|
|
fig.7.a
Kenny AP et al. (2012)
|
Xla Wt + szl MO
NF18-20 (morphology)
|
|
|
|
fig.3.a, b, d
Kenny AP et al. (2012)
|
Xla Wt + szl MO
NF20 (immunohistochemistry)
|
|
|
|
fig.5.b
Kenny AP et al. (2012)
|
Xla Wt + szl MO
NF20 (immunohistochemistry)
|
|
|
|
|
fig.3.c
Kenny AP et al. (2012)
|
Xla Wt + szl MO
NF20 (in situ hybridization)
|
|
|
|
|
fig.5.d
Kenny AP et al. (2012)
|
Xla Wt + szl MO
NF20 (in situ hybridization)
|
|
|
|
fig.6.j
Kenny AP et al. (2012)
|
Xla Wt + szl MO
NF20 (in situ hybridization)
|
|
|
|
|
fig.6.n
Kenny AP et al. (2012)
|
Xla Wt + szl MO
NF20 (in situ hybridization)
|
|
|